Latest News
- AACR Project GENIE v20.0-public is now available (242,866 patients | 289,869 samples) with newly added cfDNA samples.
- The Biopharma Collaborative (BPC) Breast v1.0-public (1,130 patients), Prostate v1.0-public (1,116 patients), Pancreas v1.0-public (1,109 patients) and Bladder v1.0-public (716 patients) cohorts, containing complete treatments and outcomes data, are now available. Visit our data page to learn more and access these cohorts.
- The AACR Project GENIE Data Model (GDM), developed by the AACR Project GENIE consortium, is an open-source, pan-cancer framework that standardizes longitudinal clinico-genomic data from diagnosis through long-term outcomes.
- AACR Project GENIE was prominently featured at the AACR Annual Meeting 2026.
- The latest GENIE publication: Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer – PMC, JCO Precision Oncology, Volume 9, April 2025.
- Watch the Believe in Progress episode: AACR Project GENIE: A Conversation with Shawn M. Sweeney, PhD, and Philippe L. Bedard, MD.
- New public data portal available from Sage Bionetworks.
- Learn more about AACR Project GENIE data included as part of sotorasib regulatory approval.
- At the 2025 Molecular Targets Meeting in Boston, Massachusetts, sessions highlighted the diverse applications of AACR Project GENIE data, including leveraging clinico-genomic information for research (Ken Kehl, DFCI), examining off-label targeted therapy utilization within Project GENIE BPC datasets (Jeremy Warner, Brown), and identifying novel drug targets through GENIE data analysis (Phillip Beer, Step Pharma).